The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group - PubMed

The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group

R L Haas et al. Eur J Cancer. 1997 Jun.

Abstract

Dermatofibrosarcoma protuberans (DFSP), a fibrohistiocytic tumour of intermediate malignancy, has a strong tendency to recur locally. Wide local excision is the recommended treatment modality. A retrospective analysis was performed on 38 consecutive DFSP patients presenting to The Netherlands Cancer Institute, to define the role of radiotherapy. Of the 21 patients treated surgically (all with negative resection margins) seven recurred, a local control probability of 67%. Combined modality treatment was given to 17 patients. Prior to radiotherapy, these patients experienced 33 occurrences of DFSP, but after irradiation only three recurrences were seen, a local control probability of 82%. These results are in keeping with the recent literature where increasing value is being given to both adjuvant and curative radiotherapy in the local management of DFSP. We recommend radiotherapy in DFSP patients where repeated surgery may cause mutilation or functional impairment.

Similar articles

• Radiotherapy in the treatment of dermatofibrosarcoma protuberans.

  Dagan R, Morris CG, Zlotecki RA, Scarborough MT, Mendenhall WM. Dagan R, et al. Am J Clin Oncol. 2005 Dec;28(6):537-9. doi: 10.1097/01.coc.0000171278.69291.64. Am J Clin Oncol. 2005. PMID: 16317260

• [Realization of clinical diagnoses and treatment for dermatofibrosarcoma protuberans].

  Cai H, Shi YQ, Wang YN, Zhu HY, Mo SJ. Cai H, et al. Zhonghua Wai Ke Za Zhi. 2004 Jun 7;42(11):678-82. Zhonghua Wai Ke Za Zhi. 2004. PMID: 15329259 Chinese.

• Dermatofibrosarcoma protuberans: a case series of 16 patients treated in a single institution with literature review.

  Archontaki M, Korkolis DP, Arnogiannaki N, Konstantinidou C, Georgopoulos S, Dendrinos P, Zarkadas G, Kokkalis G. Archontaki M, et al. Anticancer Res. 2010 Sep;30(9):3775-9. Anticancer Res. 2010. PMID: 20944168 Review.

• Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins.

  Heuvel ST, Suurmeijer A, Pras E, Van Ginkel RJ, Hoekstra HJ. Heuvel ST, et al. Eur J Surg Oncol. 2010 Jan;36(1):89-94. doi: 10.1016/j.ejso.2009.07.006. Epub 2009 Jul 31. Eur J Surg Oncol. 2010. PMID: 19646839

• Dermatofibrosarcoma protuberans: a rare entity and review of the literature.

  Stamatakos M, Fyllos A, Siafogianni A, Ntzeros K, Tasiopoulou G, Rozis M, Kontzoglou K. Stamatakos M, et al. J BUON. 2014 Jan-Mar;19(1):34-41. J BUON. 2014. PMID: 24659640 Review.

Cited by

• [Radiotherapy is effective in the adjuvant treatment of dermatofibroma protuberans].

  Fietkau R. Fietkau R. Strahlenther Onkol. 1998 Oct;174(10):541-2. Strahlenther Onkol. 1998. PMID: 9810326 German. No abstract available.

• Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

  Noujaim J, Thway K, Fisher C, Jones RL. Noujaim J, et al. Cancer Biol Med. 2015 Dec;12(4):375-84. doi: 10.7497/j.issn.2095-3941.2015.0067. Cancer Biol Med. 2015. PMID: 26779374 Free PMC article. Review.

• Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib.

  Wicherts DA, van Coevorden F, Klomp HM, van Huizum MA, Kerst JM, Haas RL, van Boven HH, van der Hage JA. Wicherts DA, et al. World J Surg Oncol. 2013 Mar 8;11:59. doi: 10.1186/1477-7819-11-59. World J Surg Oncol. 2013. PMID: 23496933 Free PMC article.

• The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.

  Malan M, Xuejingzi W, Quan SJ. Malan M, et al. Pan Afr Med J. 2019 Aug 13;33:297. doi: 10.11604/pamj.2019.33.297.17692. eCollection 2019. Pan Afr Med J. 2019. PMID: 31692830 Free PMC article. Review.

• The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review.

  Fionda B, Loperfido A, Di Stefani A, Lancellotta V, Paradisi A, De Angeli M, Cappilli S, Rossi E, Caretto AA, Zinicola T, Schinzari G, Gentileschi S, Morganti AG, Rembielak A, Peris K, Tagliaferri L. Fionda B, et al. J Clin Med. 2024 Mar 21;13(6):1798. doi: 10.3390/jcm13061798. J Clin Med. 2024. PMID: 38542022 Free PMC article. Review.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information